Preparation of Building Blocks for Carba-Oligosaccharides
83
2-O-Acetyl-3-O-benzyl-4,6-O-benzylidene-5a-carba-a-D-glucopyranos-
yl-(1 ! 6)-1,5-anhydro-3,4-di-O-benzyl-2-deoxy-D-arabino-hex-1-enitol
(12b). Compound 11b (6.4 mg, 9.6 mmol) was acetylated as in the preparation of
12a to give, after chromatography (silica gel, 2 g, 1:15 ethyl acetate/toluene, v/
1
v) to give 12b (6.7 mg, 99%) as a syrup: [a]2D2 þ218 (c 0.34, CHCl3); H NMR
(300 MHz, CDCl3) (inter alia): d 7.53–7.19 (m, 20H, 4 ꢀ Ph), 6.35 (br dd, 1H,
J1,3 ¼ 1.0 Hz, J1,2 ¼ 6.0 Hz, H-1), 5.59 (s, 1H, CHPh), 4.89 and 4.85 (ABq,
each 1H, Jgem ¼ 11.0 Hz, CH2Ph), 4.88 (dd, 1H, J2,3 ¼ 2.7 Hz, J1,2 ¼ 6.0 Hz,
H-2), 4.80 (dd, 1H, J1 ,2 ¼ 3.0 Hz, J2 ,3 ¼ 10.0 Hz, H-20), 4.19 (br dd, 1H,
J1,3 ¼ 1.0 Hz, J2,3 ¼ 2.7 Hz, J3,4 ¼ 5.7 Hz, H-3), 3.89 (dd, 1H, J3,4 ¼ 5.7 Hz,
0
0
0
0
J4,5 ¼ 8.4 Hz, H-4), 4.01 (dd, 1H, J2 ,3 ¼ J3 ,4 ¼ ꢀ10 Hz, H-30) 3.64 (br dd, 1H,
0
0
0
0
J3 ,4 ¼ J4 ,5 ¼ ꢀ11.0 Hz, H-40), 2.01 (s, 3H, Ac), 1.74 (ddd, 1H, J1 ,5a eq
¼
0
0
0
0
0
0
J5 ,5a eq ¼ 3.5 Hz, J5a gem ¼ 14.0 Hz, H-5a0eq), 1.07 (ddd, 1H, J1 ,5a ax ¼ 1.5 Hz,
0
0
0
0
0
J5 ,5a ax ¼ 13.5 Hz, J5a gem ¼ 14.0 Hz, H-5a0ax). Anal. Calcd for C43H46O9: C,
0
0
0
73.07; H, 6.56. Found: C, 72.93; H, 6.80.
3-O-Benzyl-4,6-O-benzylidene-5a-carba-b-D-glucopyranosyl-(1 ! 6)-1,
5-anhydro-3,4-di-O-benzyl-2-deoxy-D-arabino-hex-1-enitol (13b) and
3-O-Benzyl-4,6-O-benzylidene-5a-carba-b-D-mannopyranosyl-(1 ! 6)-
1,5-anhydro-3,4-di-O-benzyl-2-deoxy-D-arabino-hex-1-enitol (15b).
Compound 10b (11.7 mg, 17.7 mmol) was treated with sodium borohydride in
the presence of cerium(III) chloride in methanol as in the preparation of 13a
and 15a. The products were chromatographed on silica gel (2 g, 1:15 ethyl
acetate/toluene, v/v) to give 13b (4.6 mg, 39%) and 15b (6.5 mg, 56%) as syrups.
13b: [a]2D2 –3.48 (c 0.23, CHCl3); 1H NMR (300 MHz, CDCl3) (inter alia): d 7.51–
7.29 (m, 20H, 4 ꢀ Ph), 6.41 (dd, 1H, J1,3 ¼ 0.7 Hz, J1,2 ¼ 6.1 Hz, H-1), 5.56 (s, 1H,
CHPh), 4.88 (dd, 1H, J2,3 ¼ 2.9 Hz, J1,2 ¼ 6.1 Hz, H-2), 4.99 and 4.77 (ABq,
Jgem ¼ 11.4 Hz), 4.85 and 4.73 (ABq, Jgem ¼ 11.2 Hz), and 4.64 and 4.55 (ABq,
Jgem ¼ 11.7 Hz) (3 ꢀ CH2Ph), 4.19 (dd, 1H, J2,3 ¼ 2.9 Hz, J3,4 ¼ 6.1 Hz, H-3),
4.14 (dd, 1H, J5 6 a ¼ 4.4 Hz, J6 gem ¼ 11.1 Hz, H-60a), 4.03 (ddd, 1H,
J5,6a ¼ 3.4 Hz, J5,6b ¼ 5.1 Hz, J4,5 ¼ 8.3 Hz, H-5), 3.81 (dd, 1H, J3,4 ¼ 6.1 Hz,
0
0
0
J4,5 ¼ 8.3 Hz, H-4), 3.34 (br d, 1H, J1 ,2 ¼ 10.5 Hz, H-10), 2.83 (br s, 1H, OH),
0
0
1.00 (ddd, 1H, J1 ,5a ax ¼ 11.2 Hz, J5 ,5a ax ¼ 12.9 Hz, J5a gem ¼ 13.2 Hz, H-5a0ax).
0
0
0
0
0
15b: [a]2D3 þ248 (c 0.25, CHCl3); 1H NMR (300 MHz, CDCl3) (inter alia): d 7.48–
7.25 (m, 20H, 4 ꢀ Ph), 6.36 (dd, 1H, J1,3 ¼ 1.0 Hz, J1,2 ¼ 6.1 Hz, H-1), 5.56
(s, 1H, CHPh), 4.86 (dd, 1H, J2,3 ¼ 2.9 Hz, J1,2 ¼ 6.1 Hz, H-2), 4.81 and 4.71
(ABq, Jgem ¼ 12.3 Hz), 4.79 and 4.65 (ABq, Jgem ¼ 11.6 Hz), and 4.59 and
0
0
4.48 (ABq, Jgem ¼ 11.7 Hz) (3 ꢀ CH2Ph), 4.24 (br dd, 1H, J1 ,2 ¼ 2.2 Hz,
J2 ,3 ¼ 2.8 Hz, H-20), 3.63 (dd, 1H, J5 ,6 a ¼ 10.6 Hz, J6 gem ¼ 10.7 Hz, H-60a),
0
0
0
0
0
3.39 (dd, 1H, J2 ,3 ¼ 2.8 Hz, J3 ,4 ¼ 9.6 Hz, H-30), 3.30 (m, 1H, J1 ,2 ¼ 2.2 Hz,
0
0
0
0
0
0
J1 ,5a eq ¼ 6.6 Hz, J1 ,5a ax ¼ 9.3 Hz, H-10), 2.43 (br s, 1H, OH).
0
0
0
0